331A
Medix Inc.
メディックス
- Industry
- Services
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Consolidation basisConsolidated / Since Mar 2026
Key metrics
Revenue(thousand JPY)
Mar 2025
4,161,843
Mar 2026
4,256,886
Operating profit(thousand JPY)
Mar 2025
802,568
Mar 2026
659,413
Operating profit margin(%)
Mar 2025
19.28
Mar 2026
15.49
Profit before tax(thousand JPY)
Mar 2025
951,856
Mar 2026
661,754
Profit(thousand JPY)
Mar 2025
803,690
Mar 2026
436,970
Total assets(thousand JPY)
Mar 2025
6,669,568
Mar 2026
7,732,233
Cash and cash equivalents(thousand JPY)
Mar 2025
3,771,068
Mar 2026
4,064,327
Cash flows from operating activities(thousand JPY)
Mar 2025
499,948
Mar 2026
252,733
Cash flows from investing activities(thousand JPY)
Mar 2025
414,355
Mar 2026
-322,218
Cash flows from financing activities(thousand JPY)
Mar 2025
76,286
Mar 2026
362,208
Return on equity(%)
Mar 2025
29.6
Mar 2026
12.7
Equity ratio(%)
Mar 2025
49
Mar 2026
44.4
Earnings per share(JPY per share)
Mar 2025
106.5
Mar 2026
56.16
Net assets per share(JPY per share)
Mar 2025
407.06
Mar 2026
448.19
Dividend per share(JPY per share)
Mar 2025
14
Mar 2026
18
Payout ratio(%)
Mar 2025
13.15
Mar 2026
32.05
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.